Patents by Inventor Suvi JAIN

Suvi JAIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS RELATING TO HIGH-THROUGHPUT MODELS FOR ANTIBODY DISCOVERY AND/OR OPTIMIZATION
    Publication number: 20240352154
    Abstract: Described herein are compositions (e.g. cells and transgenic animals) and methods relating to engineered Ig loci that permit expression of particular antibodies or antibody segments while still permitting recombination and/or maturation process for antibody optimization.
    Type: Application
    Filed: March 18, 2024
    Publication date: October 24, 2024
    Applicant: THE CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Frederick W. ALT, Suvi JAIN, Zhaoqing BA, Ming TIAN
  • CD24-ASSOCIATED PARTICLES AND RELATED METHODS AND USES THEREOF
    Publication number: 20220333132
    Abstract: Provided herein are non-cell particles, e.g. virus particles or virus-like particles, such as pseudotyped lentiviral-like particles, containing an exogenous CD24 or a biologically active portion of CD24. In some embodiments, the non-cell particles, e.g. virus particles or virus-like particles, such as pseudotyped lentiviral-like particles, can further contain an exogenous CD47 or a biologically active portion of CD47. Also provided herein are compositions containing such non-cell particles and methods of making and using the non-cell particles.
    Type: Application
    Filed: September 2, 2020
    Publication date: October 20, 2022
    Applicant: Sana Blotechnology, Inc.
    Inventors: Akinola Olumide EMMANUEL, Hanane ENNAJDAOUI, Suvi JAIN, Alberto RUZO MATIAS, Jagesh V. SHAHA
  • METHODS AND COMPOSITIONS RELATING TO HIGH-THROUGHPUT MODELS FOR ANTIBODY DISCOVERY AND/OR OPTIMIZATION
    Publication number: 20210238312
    Abstract: Described herein are compositions (e.g. cells and transgenic animals) and methods relating to engineered Ig loci that permit expression of particular antibodies or antibody segments while still permitting recombination and/or maturation process for antibody optimization.
    Type: Application
    Filed: June 10, 2019
    Publication date: August 5, 2021
    Applicant: THE CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Frederick W. ALT, Suvi JAIN, Zhaoqing BA, Ming TIAN